Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

AASLD news: optimal phase III anti-HBV dose of Coviracil selected from phase I/II data

Nov. 7, 2000

SAR leading to APC-2059, a potent and selective human mast cell tryptase inhibitor

Nov. 7, 2000

Antiviral agents for hepatitis emerge from R&D at CSIRO

Nov. 6, 2000

AASLD news: F-180 displays beneficial effects in portal hypertension-related bleeding

Nov. 6, 2000

Clevudine phase I trial results presented at AASLD meeting

Nov. 6, 2000

Combination therapy including Maxamine proves effective and safe in chronic HCV

Nov. 6, 2000

Clinical results for entecavir presented at AASLD meeting

Nov. 3, 2000

First combination monoclonal antibody therapy for chronic HBV shows promise in phase I

Nov. 3, 2000

InKine selects tradenames for CBP-1011

Oct. 31, 2000

Promising new colon-specific 5-ASA prodrug developed by U.S. and Korean scientists

Oct. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...